105 related articles for article (PubMed ID: 6821012)
1. A double blind controlled trial of Bencard house dust mite (Migen) hyposensitisation in Zambian asthmatics.
Buchanan DJ; Hillis A; Williams PN
Med J Zambia; 1980 Dec-1981 Jan; 15(1):14-6. PubMed ID: 6821012
[TBL] [Abstract][Full Text] [Related]
2. [Radioimmunologic tests in specific immunotherapy of atopic rhinitis].
Ligeziński A
Wiad Lek; 1984 Dec; 37(23):1846-50. PubMed ID: 6442498
[No Abstract] [Full Text] [Related]
3. [Specific immunotherapy in the treatment of hay fever].
Obtułowicz K
Pol Tyg Lek; 1988 Jan 18-25; 43(3-4):97-101. PubMed ID: 3133645
[No Abstract] [Full Text] [Related]
4. Immunotherapy with glutaraldehyde treated tyrosine adsorbed grass pollen in the treatment of allergic rhinitis.
Small P; Shapiro M
Ann Allergy; 1981 Dec; 47(6):443-5. PubMed ID: 6798900
[No Abstract] [Full Text] [Related]
5. The effect of immunotherapy in hayfever patients on histamine binding capacity of blood serum proteins.
Zak-Nejmark T; Małolepszy J; Nadobna G; Ossos M; Liebhart J
Arch Immunol Ther Exp (Warsz); 1987; 35(5):693-7. PubMed ID: 3138963
[TBL] [Abstract][Full Text] [Related]
6. [Changes in allergen-specific IgG-4 during desensitization of patients with hay fever and those sensitized to housedust allergens].
Kruszewski J
Pneumonol Alergol Pol; 1991; 59 Suppl 1():31-9. PubMed ID: 1843806
[No Abstract] [Full Text] [Related]
7. IgG and IgE antibody response following Pollinex-R immunotherapy.
Ko HS; Chen SJ; Jaworska E
Ann Allergy; 1987 Dec; 59(6):441-9. PubMed ID: 3122605
[TBL] [Abstract][Full Text] [Related]
8. [Leukocyte migration inhibition test in patients with pollen-induced asthma and the results of hyposensitization therapy with Pollinex].
Grzegorczyk J; Rozniecki J; Kałła M
Pneumonol Pol; 1984 Mar; 52(3):123-30. PubMed ID: 6427758
[No Abstract] [Full Text] [Related]
9. Migen in the treatment of perennial rhinitis.
Cooper B
Br J Clin Pract; 1979; 33(11-12):323-4. PubMed ID: 540088
[No Abstract] [Full Text] [Related]
10. [Blood basophil histamine and immunoglobulin levels in children with bronchial asthma treated with Pollinex].
Fal W; Jankowski A; Barańska B; Galary E; Latoś T
Pediatr Pol; 1987 Jul; 62(7):463-8. PubMed ID: 3122156
[No Abstract] [Full Text] [Related]
11. [Effect of stimulation of beta-adrenergic and H2 receptors of polymorphonuclear granulocytes on the release of lysosomal enzymes in patients with hay fever before and after treatment with Pollinex].
Wrzyszcz M; Małolepszy J
Pol Tyg Lek; 1985 Mar 25-31; 40(12-13):377-9. PubMed ID: 2989805
[No Abstract] [Full Text] [Related]
12. The advances of hyposensibilisation therapy in bronchial asthma patients allergic to house dust antigen.
Romański B; Pawlik K; Wilawska-Kłubo T
Allerg Immunol (Leipz); 1977; 23(3):211-3. PubMed ID: 147019
[TBL] [Abstract][Full Text] [Related]
13. Human IgG antibody responses to grass pollen antigens: effects of immunotherapy and comparison of serum and secretory profiles.
Deards MJ; Standring R; Moran DM
Int Arch Allergy Appl Immunol; 1986; 80(3):253-7. PubMed ID: 3087884
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy and safety of two preseasonal regimens of glutaraldehyde modified, tyrosine-adsorbed parietaria pollen extract over a period of three years in monosensitive patients.
Negro JM; Wheeler AW; Hernández J; Youlten LJ; Pascual A; García-Sellés FJ; Pagán JA; López-Sánchez JD; Miralles JC; Sarrió F; Milán JM; Contreras LG; Vidal D
Allergol Immunopathol (Madr); 1999; 27(3):153-64. PubMed ID: 10431101
[TBL] [Abstract][Full Text] [Related]
15. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
[TBL] [Abstract][Full Text] [Related]
16. Depigmented and polymerised house dust mite allergoid: allergen content, induction of IgG4 and clinical response.
Gallego MT; Iraola V; Himly M; Robinson DS; Badiola C; García-Robaina JC; Briza P; Carnés J
Int Arch Allergy Immunol; 2010; 153(1):61-9. PubMed ID: 20357486
[TBL] [Abstract][Full Text] [Related]
17. Steroid-sparing effect of subcutaneous SQ-standardised specific immunotherapy in moderate and severe house dust mite allergic asthmatics.
Blumberga G; Groes L; Haugaard L; Dahl R
Allergy; 2006 Jul; 61(7):843-8. PubMed ID: 16792582
[TBL] [Abstract][Full Text] [Related]
18. Allergen immunotherapy.
Wheeler AW
Clin Exp Allergy; 1995 Apr; 25(4):379. PubMed ID: 7600384
[No Abstract] [Full Text] [Related]
19. Hyposensitisation with house dust mite vaccine in bronchial asthma.
Gaddie J; Skinner C; Palmer KN
Br Med J; 1976 Sep; 2(6035):561-2. PubMed ID: 786429
[TBL] [Abstract][Full Text] [Related]
20. [Comparative studies of the effectiveness of specific immunotherapy in house dust mite allergy].
Ebner H; Neuchrist C; Havelec L; Kraft D
Wien Klin Wochenschr; 1989 Aug; 101(15):504-11. PubMed ID: 2672610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
